- Home
- HVT vs VERV Comparison
HVT vs VERV Comparison
Compare HVT & VERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HVT
- VERV
- Stock Information
- Founded
- HVT 1885
- VERV 2018
- Country
- HVT United States
- VERV United States
- Employees
- HVT N/A
- VERV N/A
- Industry
- HVT Other Specialty Stores
- VERV Medicinal Chemicals and Botanical Products
- Sector
- HVT Consumer Discretionary
- VERV Health Care
- Exchange
- HVT Nasdaq
- VERV Nasdaq
- Market Cap
- HVT 425.1M
- VERV 382.5M
- IPO Year
- HVT N/A
- VERV 2021
- Fundamental
- Price
- HVT $23.10
- VERV $4.60
- Analyst Decision
- HVT Strong Buy
- VERV Strong Buy
- Analyst Count
- HVT 1
- VERV 4
- Target Price
- HVT $45.00
- VERV $25.75
- AVG Volume (30 Days)
- HVT 205.9K
- VERV 1.6M
- Earning Date
- HVT 10-30-2024
- VERV 11-05-2024
- Dividend Yield
- HVT 5.51%
- VERV N/A
- EPS Growth
- HVT N/A
- VERV N/A
- EPS
- HVT 1.60
- VERV N/A
- Revenue
- HVT $749,290,000.00
- VERV $24,396,000.00
- Revenue This Year
- HVT N/A
- VERV $84.66
- Revenue Next Year
- HVT $5.38
- VERV N/A
- P/E Ratio
- HVT $14.43
- VERV N/A
- Revenue Growth
- HVT N/A
- VERV 219.91
- 52 Week Low
- HVT $21.61
- VERV $4.31
- 52 Week High
- HVT $37.05
- VERV $19.34
- Technical
- Relative Strength Index (RSI)
- HVT 45.81
- VERV 34.98
- Support Level
- HVT $22.23
- VERV $4.48
- Resistance Level
- HVT $23.29
- VERV $4.93
- Average True Range (ATR)
- HVT 0.66
- VERV 0.49
- MACD
- HVT 0.15
- VERV -0.21
- Stochastic Oscillator
- HVT 70.77
- VERV 6.75
About HVT Haverty Furniture Companies Inc.
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates primarily in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of its revenue from its upholstery products and, secondarily, from bedroom furniture.
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.